Marken establishs a cGMP cold-chain center in Korea

expected to standarize the distribution system in Korea

Marken and its parent company UPS’s cold-chain distribution center for pharmaceuticals will be complete by October

The 1,000 pyeong sized center will offer freezing, refrigerating, cryogenic preservation systems… has liquid nitrogen (LN2) repositories

Expected to act as an import and export hub for vaccines, biologics, cell and gene therapies in Korea and abroad

Image of Marken’s cold-chain logistics center that will be established near the Incheon Airport in October this year

A cGMP compliant cold-chain center for the distribution of pharmaceuticals that will soon be complete in Korea is receiving attention.

 

According to industry sources, the global biopharmaceutical·clinical trial logistics company Marken and its parent company UPS have worked together to establish a 1,000-pyeong cold chain storage and distribution center in Korea.

 

The center will be completed in October.

 

The importance of the cold-chain system has emerged in the process of distributing COVID-19 mRNA vaccines.

 

Marken’s establishment of the new distribution center near the Incheon Airport is expected to contribute to the establishment of an upgraded biopharmaceutical distribution standard in Korea.

 

An official from Marken Korea said, “To respond quickly to the surge in demand for cold-chain storage and shipping of pharmaceuticals in Korea and abroad, the company had begun construction of a GMP-compliant pharmaceutical storage and distribution center in June, which will be complete in October this year.” The Marken Cold-chain Distribution Center will be around 3305 square meters (approximately 1000 pyeong) and be equipped with various facilities suited for storage of clinical drug products, medical devices, vaccines, and biologics that require temperature control at room temperature (+15 to +8°C) or refrigeration (+2 to +8°C), freezing (15 to -25°C), and cryogenic (-80°C) storage.

 

In addition, a liquid nitrogen (LN2) storage unit will also be prepared for the exclusive storage of cell and gene therapies.

 

Marken has a logistics network in 17 countries in the Asia-Pacific region.

 

With the opening of the Incheon Airport logistics center, the company will have a total of 7 GMP cold-chain drug storage facilities, 4 liquid nitrogen filling locations, and 2 clinical kit production facilities in Asia.

 

Marken currently manages 110,000 cold-chain drug product and biological sample shipments every month in more than 220 countries around the globe.

 

The company uses a GPS tracking system to track the route of all products in real-time and operates a 24-hour global control center that monitors and manages the tracking system.

 

Also, the company offers differentiated and specialized services such as validation for the full course from storage, distribution to shipment of pharmaceuticals, and regulatory and compliance consulting services for each country.

 

For more information on the storage and distribution of pharmaceuticals products in Korea and overseas, please contact [e-mail].